HealthQuest News

Garheng Kong named top 25 healthcare investors of 2026 by GrowthCap

24 March 2026
< Back to News

A physician, scientist, and engineer by training, Garheng Kong has over two decades of experience investing in innovative companies in all areas of healthcare and has led over 40 companies to successful exits (IPO and M&A). 

Garheng is the Managing Partner and Founder of HealthQuest Capital, a private asset firm that currently provides growth capital to transformative companies that are improving value in the healthcare system. Prior to founding HealthQuest, Garheng was a partner at Intersouth Partners and Sofinnova Investments, and has also spent time at GlaxoSmithKline and McKinsey, and as a CEO of two healthcare companies. 

Garheng also serves as Lead Director of LabCorp (LH) and on the boards of Smith & Nephew PLC (SNN), Xeris Biopharma Holdings (XERS), IKS Health (NSE: IKS), Duke University Health System, Duke University Board of Trustees, Dell Children’s Foundation, UT Medicine, UT President’s Commercial Advisory Board, and the Austin Healthcare Council Board. He is an Aspen Institute Health Innovators Fellow, Kauffman Fellows Mentor, and member of YPO. 

Garheng received undergraduate degrees in both chemical engineering and biological sciences from Stanford, while on an athletic scholarship, and earned MD, PhD, and MBA degrees from Duke University.

“I’m honored to be recognized as a Top Healthcare Investor for 2026. Healthcare is complex and constantly evolving, and we approach it with a deep sense of responsibility to patients, providers, and the broader system. This acknowledgment reflects the strength of our team and the founders we’re privileged to support. They are building durable companies that address real gaps in care and create lasting value. We’re grateful for the trust they place in us and remain committed to backing businesses that combine strong fundamentals with meaningful impact.” — Garheng Kong

Speak to us.

 

Contact Us.